![]() Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. | ||
Founding Date | Founding Date 2007 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Somerville, US HQ |
Employees | Employees 17 | Employees 32338% decrease |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 95.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) €21k (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) |
Cost of goods | Cost of goods €8k (FY, 2025) | Cost of goods $89.4m (FY, 2024) |
Gross profit | Gross profit €5.9m (FY, 2025) | Gross profit ($5.6m) (FY, 2024) |
Net income | Net income €830k (FY, 2025) | Net income ($240.7m) (FY, 2024) |

Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company